Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1982-5-12
|
pubmed:abstractText |
Receptors for 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] have been described in several human breast cancer cell lines and more recently in human melanoma. The presence of 1,25-(OH)2D3 receptor (1,25-DR) in two cultured breast cancer cell lines was associated with receptors for calcitonin, another hormone thought to have effects on calcium handling. Therefore, it seemed important to examine a range of established human cancer cell lines for the presence of receptors for 1,25-(OH)2D3 and calcitonin. Thirty-three cancer cell lines were examined. 1,25-DR was found to be present in 23 lines, while calcitonin receptors were not detected in any of them. The 1,25-DR from several cell lines sedimented at about 3.5S in sucrose density gradients, had the appropriate specificity for vitamin D metabolites, had Kds of 0.8 to 2.2 x 10(-11) M, and had receptor concentrations of 12 to 99 fmol/mg protein. Ten malignant melanoma and nine colonic carcinoma lines constituted the largest groups of carcinoma cell lines, and seven and eight, respectively, of these were 1,25-DR positive. The high frequency of 1,25-DR positivity in the cultured colonic carcinoma cells is quite different from the low frequency of 1,25-DR in primary colonic carcinomas. It was also interesting that both of two cell lines derived from patients who had had both bone metastases and malignant hypercalcemia were 1,25-DR positive. These various cell lines may provide useful models for the examination of 1,25-(OH)2D3 action in vitro.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1116-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6277475-Binding, Competitive,
pubmed-meshheading:6277475-Breast Neoplasms,
pubmed-meshheading:6277475-Calcitonin,
pubmed-meshheading:6277475-Calcitriol,
pubmed-meshheading:6277475-Cell Line,
pubmed-meshheading:6277475-Centrifugation, Density Gradient,
pubmed-meshheading:6277475-Colonic Neoplasms,
pubmed-meshheading:6277475-Female,
pubmed-meshheading:6277475-Humans,
pubmed-meshheading:6277475-Hypercalcemia,
pubmed-meshheading:6277475-Kinetics,
pubmed-meshheading:6277475-Lung Neoplasms,
pubmed-meshheading:6277475-Melanoma,
pubmed-meshheading:6277475-Receptors, Cell Surface,
pubmed-meshheading:6277475-Receptors, Steroid,
pubmed-meshheading:6277475-Urogenital Neoplasms
|
pubmed:year |
1982
|
pubmed:articleTitle |
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|